Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (5)
  • Open Access

    CASE REPORT

    Case Report: Prominent Coronary Artery Flow in Fetuses with Congenital Heart Disease, Is It a Marker of In Utero Distress?

    Mohamed Aashiq Abdul Ghayum1,*, Maria Kiaffas1,2, Ashley Warta1, Melanie Kathol1, David C. Mundy2, Kelsey Brattrud1, Nitin Madan1,2

    Congenital Heart Disease, Vol.19, No.6, pp. 647-651, 2024, DOI:10.32604/chd.2025.058271 - 27 January 2025

    Abstract Prominent coronary artery (CA) flow observed on a fetal echocardiogram has been associated with fetal growth restriction and myocardial dysfunction. We present two cases with this finding, in the presence of congenital heart disease (CHD) and absence of growth restriction or myocardial dysfunction. Both the cases rapidly progressed to extremis, necessitating emergent delivery. Our cases highlight the importance of recognizing prominent CA flow in fetuses with CHD as a potential marker for in utero distress. More >

  • Open Access

    ARTICLE

    Maternal Vascular Dysfunction in Congenital Heart Defects

    Yanli Liu1,2, Fengzhen Han2, Jian Zhuang4, Yanqiu Ou4, Yanji Qu5, Yanyan Lin2, Weina Zhang2, Haiping Wang3,*, Liping Huang1,*

    Congenital Heart Disease, Vol.18, No.5, pp. 561-570, 2023, DOI:10.32604/chd.2023.030511 - 10 November 2023

    Abstract Background: Research on fetal congenital heart defect (CHD) mostly focuses on etiology and mechanisms. However, studies on maternal complications or pathophysiology are limited. Our objective was to determine whether vascular dysfunction exists in pregnant women carrying a fetus with congenital heart defects. Methods: We conducted a case-control study. 27 cases of pregnant women carrying a fetus with major CHD admitted to our hospital for delivery between April 2021 and August 2022 were selected. Every case was matched with about 2 pregnant complication-free controls without fetal abnormalities. The proangiogenic and anti-angiogenic factors and pregnancy outcomes were… More > Graphic Abstract

    Maternal Vascular Dysfunction in Congenital Heart Defects

  • Open Access

    ARTICLE

    Quantitative Parameters Analysis for Prenatally Echocardiographic Diagnosis of Atrioventricular Septal Defects

    Xiaoxue Zhou1, Tingyang Yang2, Ye Zhang1, Yanping Ruan1, Jiancheng Han1, Xiaowei Liu1, Ying Zhao1, Xiaoyan Gu1, Tingting Liu1, Hairui Wang1, Yihua He1,*

    Congenital Heart Disease, Vol.18, No.3, pp. 387-397, 2023, DOI:10.32604/chd.2023.029060 - 09 June 2023

    Abstract Background: Atrioventricular septal defects (AVSDs) are screened and diagnosed usually rely on the imaging characteristics of fetal echocardiography (FE). However, diagnosis on images is heavily depended on sonographers’ experience and the quantitative data are rarely studied. Objective: This study aimed to realize the prenatal diagnosis of AVSDs by analyzing the quantitative data on FE. Methods: One hundred and thirteen cardiac quantitative data was analyzed in 370 normal and 49 AVSDs fetuses retrospectively. The top six with the highest diagnostic accuracy rate were acquired according to the area under the curve (AUC), and the diagnostic value of… More >

  • Open Access

    ARTICLE

    Two approaches for calculating female fetal DNA fraction in noninvasive prenatal testing based on size analysis of maternal DNA fragments

    JIANBO LU1,2,#,*, XIAOHAN SUN3,#, XU MA1,2,*

    BIOCELL, Vol.46, No.1, pp. 185-193, 2022, DOI:10.32604/biocell.2021.015301 - 29 September 2021

    Abstract The concentration of cell-free fetal DNA fragments should be detected before noninvasive prenatal testing (NIPT). The fetal DNA molecules have significant clinical potential in determining the overall performance of NIPT and clinical interpretation. It is important to measure fetal DNA fraction before NIPT. However, there is still little research on how to calculate the concentration of female fetuses. Two estimation approaches were proposed to calculate fetal DNA fraction, including the fragments size-based approach, aneuploid-based approach, which are all approaches based on chromosome segments. Based on high-throughput sequencing data, two approaches to calculate the DNA fraction More >

  • Open Access

    CASE REPORT

    Fetus in fetu

    A. M. Kajbafzadeh1, M. Baharnoori2

    Canadian Journal of Urology, Vol.13, No.5, pp. 3277-3278, 2006

    Abstract Fetus in fetu (FIF) is a very rare condition, with a reported incidence of one in 500,000 live births. It most likely represents a monozygotic diamniotic twin that implants itself and grows within the body of its normal, karyotypically identical sibling, which typically manifests as a fetiform abdominal mass in a newborn or infant.
    The mass is located in the retroperitoneum in most cases, including our example, and is commonly surrounded by encapsulated fluid. However, FIF has been reported to occur in other locations, such as within the cranium, the scrotum, and the oral cavity. Usually… More >

Displaying 1-10 on page 1 of 5. Per Page